Report of Foreign Issuer (6-k)
2019年2月25日 - 10:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2019
Commission File Number: 333-219066
Clementia Pharmaceuticals Inc.
(Translation of registrant
’
s
name into English)
4150 Sainte-Catherine Street West,
Suite 550
Montreal, Quebec, Canada H3Z 2Y5
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
ý
Form 40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
DOCUMENTS FURNISHED AS PART OF THIS FORM
6-K
A press release dated February 25, 2019.
Exhibits
99.1 – Press Release dated February
25, 2019
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
Clementia Pharmaceuticals Inc.
|
|
(Registrant)
|
|
|
Date: February 25, 2019
|
By:
/s/ Steve Forte
|
|
Steve Forte
|
|
Chief Financial Officer
|
Clementia Pharmaceuticals Inc. (NASDAQ:CMTA)
過去 株価チャート
から 5 2024 まで 6 2024
Clementia Pharmaceuticals Inc. (NASDAQ:CMTA)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Clementia Pharmaceuticals Inc. (ナスダック市場): 0 recent articles
その他のClementia Pharmaceuticals Inc.ニュース記事